Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Dropped 69.8% in First Quarter of 2023

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 250.7 million yuan in the first quarter of 2023, down 69.8% year-on-year.

Meanwhile, the company posted 665.4 million yuan in revenue, down 25% year-on-year.

At the end of the reporting period, it had 7 billion yuan in total assets and 200 million yuan in total liabilities, with a liability-to-asset ratio of 2.9%.